ACADIA Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2015

by Business Wire • 2015/07/30 • 0 Comments

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2015 on Thursday, August 6, 2015, after the U.S. financial markets close. ACADIA's management will host a conference call and

← OSNAPAO: Should we use prophylaxis topical antibiotics after intravitreal injections?

Glaukos Corporation Receives Regulatory Approval in Australia for iStent inject® →

Post navigation